EDMONTON, AB, June 30, 2022 /PRNewswire/ - Nanostics Inc., a precision health diagnostics company, today announces positive data from a pre-biopsy clinical validation study of its ClarityDX Prostate ® ...
Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...
The state Department of Health is partnering with Diagnostic Laboratory Services and Clinical Laboratories of Ha-wai’i to encourage providers to do “reflex” hepatitis C testing, in hopes of screening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback